{
    "2018-07-06": [
        [
            {
                "time": "2018-06-30",
                "original_text": "Pharma Stock Roundup: NVS to Divest Eye Care Unit, CHMP Gives Nod to Several Drugs",
                "features": {
                    "keywords": [
                        "NVS",
                        "Divest",
                        "Eye Care Unit",
                        "CHMP",
                        "Drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "Analyzing Novartis’s Alcon over Recent Quarters",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Alcon",
                        "Recent Quarters"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "How Novartis Stock Did in June",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Stock",
                        "June"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "How Novartis’s Sandoz Has Performed",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Sandoz",
                        "Performed"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "generic drugs"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "The Swiss Stock Market Clung To A Small Gain",
                "features": {
                    "keywords": [
                        "Swiss",
                        "Stock Market",
                        "Small Gain"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "A Look at Novartis’s Innovative Medicines Business",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Innovative Medicines",
                        "Business"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}